Eosinophilia Clinical Trials

4 recruiting

Eosinophilia Trials at a Glance

8 actively recruiting trials for eosinophilia are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Bethesda, Lille, and Ankara. Lead sponsors running eosinophilia studies include National Institute of Allergy and Infectious Diseases (NIAID), Matthias Griese, and Austin Health.

Browse eosinophilia trials by phase

Treatments under study

About Eosinophilia Clinical Trials

Looking for clinical trials for Eosinophilia? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Eosinophilia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Eosinophilia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

EosinophiliaHypereosinophilic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID)50 enrolled1 locationNCT00091871
Recruiting

Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia

Immune System DiseasesEosinophiliaHelminthiasis+2 more
National Institute of Allergy and Infectious Diseases (NIAID)800 enrolled1 locationNCT00001406
Recruiting
Phase 3

A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases

Eosinophilic Granulomatosis With Polyangiitis (EGPA)Hypereosinophilia Syndrome (HES)
AstraZeneca14 enrolled15 locationsNCT06512883
Recruiting

Natural History of Hypereosinophilia and Hypereosinophilic Syndromes

EosinophiliaHypereosinophilic Syndrome
University Hospital, Lille600 enrolled1 locationNCT04018118
Recruiting
Not Applicable

Specific Versus Empirical Anthelminthic Treatment in Eosinophilia

Eosinophilia
Prince of Songkla University700 enrolled1 locationNCT06265870
Recruiting

European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank

Lung Diseases, InterstitialPulmonary FibrosisChild+3 more
Matthias Griese1,000 enrolled3 locationsNCT02852928
Recruiting

Mepolizumab for treatment of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome - A pilot study

DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndrome
St Vincent's Hospital, Sydney8 enrolled6 locationsACTRN12621001333808
Recruiting

Australian Registry of Severe Drug Reactions

Drug Reaction with Eosinophilia and Systemic SymptomsToxic Epidermal NecrolysisStevens-Johnson Syndrome+3 more
Austin Health500 enrolled17 locationsACTRN12619000241134